Haijun Gu
6PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 06, 2023
Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer.Haijun Gu, Ting Zhang, Tian Guan
|May 22, 2023
Discovery of Pyrimidinediamine Derivatives as Potent Methuosis Inducers for the Treatment of Triple-Negative Breast Cancer.Jia He, Luzhen Wang, DaZhao Mi
|Nov 28, 2022
B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas.Haijun Gu, Jia He, Yuzhan Li
|Sep 27, 2022
Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer.Haijun Gu, Ting Zhang, Yunqi Li
|Sep 14, 2022
Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr705/Ser727 Inhibitory Activity for Gastric Cancer Treatment.Peng He, Ying Miao, Yue Sun
|Jan 03, 2020
Synthesis and Biological Evaluation of B-Cell Lymphoma 6 Inhibitors of N-Phenyl-4-pyrimidinamine Derivatives Bearing Potent Activities against Tumor Growth.Weikai Guo, Yajing Xing, Qiansen Zhang
Pageof 1
Frequent Collaborators
6 joint publications
Yihua Chen
3 joint publications
Peng He
3 joint publications
Dazhao Mi
3 joint publications
Mingyao Liu
3 joint publications
Zhengfang Yi
2 joint publications
Weikai Guo
2 joint publications
Yangrui Peng
1 joint publications
Yajing Xing
1 joint publications
Qiansen Zhang
1 joint publications
Yunqi Li
